CRISPR-based editing is described as a gene-therapy approach used to correct pathogenic mutations in podocytopathies.
First-pass extracted concept
CRISPR-based editing
Candidate: toolkit itemType: engineering method1 source documents2 linked claims
Live refresh every 5sNext refresh in 5s
Aliases
CRISPR
Extracted Explainers
What the tool is doing
What problem it solves
Evidence Snippets
Supporting Sources
Linked Claims
Gene therapy has emerged as a transformative approach for podocytopathies using AAV vectors, CRISPR-based editing, and RNA modulation to correct pathogenic mutations or restore disrupted pathways.
Immune responses, vector biodistribution, and disease heterogeneity remain challenges for podocytopathy gene therapy.